Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

ADHERIUM LIMITED

INVESTOR PRESENTATION - ADHERIUM LIMITED

ASX:ADR

ADHERIUM LIMITED

Health Care

Adherium Limited (ADR) develops, manufactures and supplies digital health technologies which address sub-optimal medication use in chronic disease. Adherium operates globally from bases in New Zealand, Australia, USA and UK.

Market Cap

$21.71m

Price at Close

$0.032

4w avg. Volume

858.61k

4w avg. Turnover

$23.69k

Announcements
announcementt+2 movementdate
  • Adherium agrees rollout to specialist US respiratory centres

    Progress Report · Market sensitive

  • +17.86%

    23 Nov 2020

+17.86%

23 Nov 2020
  • Adherium reports positive HGE Health pilot progress

    Progress Report

  • +4.76%

    03 Nov 2020

+4.76%

03 Nov 2020
  • Notice of Annual General Meeting/Proxy Form

    Notice Of Meeting

  • -8.70%

    30 Oct 2020

-8.70%

30 Oct 2020
  • Cleansing notice under s708A of the Corporations Act

    Issued Capital

  • 0.00%

    28 Oct 2020

0.00%

28 Oct 2020
  • Appendix 4C - quarterly

    Commitments test entity quarterly reports · Market sensitive

  • 0.00%

    28 Oct 2020

0.00%

28 Oct 2020
  • Appendix 3G - corrected

    Issued Capital

  • 0.00%

    28 Oct 2020

0.00%

28 Oct 2020
  • Cleansing Notice under s708A(12C)(e) of the Corporations Act

    Issued Capital

  • 0.00%

    25 Oct 2020

0.00%

25 Oct 2020
  • Appendix 3G

    Issued Capital

  • 0.00%

    25 Oct 2020

0.00%

25 Oct 2020
  • Adherium secures $3m funding from Viburnum

    Issued Capital · Market sensitive

  • 0.00%

    25 Oct 2020

0.00%

25 Oct 2020
  • Appendix 3G - ESOP

    Issued Capital

  • 0.00%

    22 Oct 2020

0.00%

22 Oct 2020
Market Data

Current Price

$0.032

52WK HIGH

$0.051

52WK LOW

$0.011

1YR RETURN

-15.79%

1YR RETURN VS. SECTOR

-52.05%

90 DAY RETURN

-15.79%

ASX RANK

1,442

/2,026

SECTOR RANK

12

/18

SHARES OUTSTANDING

678.53m
ASX:ADR

ADHERIUM LIMITED

Health Care

Adherium Limited (ADR) develops, manufactures and supplies digital health technologies which address sub-optimal medication use in chronic disease. Adherium operates globally from bases in New Zealand, Australia, USA and UK.

Market Cap

$21.71m

Price at Close

$0.032

4w avg. Volume

858.61k

4w avg. Turnover

$23.69k

ASX:ADR is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.